Piotr K Krajewski1, Piotr Olczyk2, Magdalena Krajewska2, Wojciech Krajewski3, Jacek C Szepietowski1. 1. Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland. 2. Department of Nephrology and Transplantation Medicine, Wroclaw Medical University, Wroclaw, Poland. 3. Department of Urology and Oncologic Urology, Wrocław Medical University, Wrocław, Poland.
Abstract
Background: Chronic itch is the most common symptom in dermatology. End-stage renal disease-associated chronic itch (ESRDCI) is a common burden affecting up to 35% of patients treated with hemodialysis. Kidney transplant (KTx) is believed to be the best renal replacement therapy leading to the elimination of ESRDCI. The study was undertaken to characterize and assess the prevalence of itch among patients after renal transplantation. Methods: Between October 2019 and January 2020, we analyzed the data of 197 patients comprising 121 males (61.4%) and 76 females (38.6%) and aged 54.5 ± 13.6 years. The data collection was performed with a specially designed questionnaire. Level of itch after renal transplantation was assessed with the use of a Numeral Rating Scale, a Visual Rating Scale, and 4-Item Itch Questionnaire. Moreover, the previous 3 days of itching were evaluated. Results: The patients suffered from chronic renal disease for 20.2 ± 12.3 years, with a mean time of pre-transplant dialysis of 2.6 ± 2.4 years and a mean time after the KTx of 8.0 ± 6.5 years. The itch was present in 38.6% of the patients during the hemodialysis, and in 73.7% of cases, the itch ceased completely after the successful transplantation. Moreover, only 2.63% of the cases had no improvement. Nevertheless, the itch was reported in 42 (21.3%) renal transplant recipients (RTR), and in 22 (52.4%) cases, the itch appeared after transplantation. The majority of patients suffering from itch were women (54.8%). Itch in the last 3 days was reported in 21 patients. The itch's severity was assessed with a numerical rating scale (NRS), with the worst severity measured at 6 ± 2.2 points indicating moderate itch. In most cases (57.1%), itch affected multiple body areas. Extremities (50%) and the back (50%) were among the most frequently affected areas. The sensation had a mostly short duration and was most frequently reported in the evening. Only eight patients suffered for the whole day. Hot water was the most frequently reported (16.7%) alleviating factor, whilst sweat was responsible for itch aggravation in 35.9% of cases. Conclusion: Our analysis on representative patients' population indicates that itch after KTx is an important problem. Moreover, it is worth noting that more than half of the RTR did not suffer from itch during dialysis.
Background: Chronic itch is the most common symptom in dermatology. End-stage renal disease-associated chronic itch (ESRDCI) is a common burden affecting up to 35% of patients treated with hemodialysis. Kidney transplant (KTx) is believed to be the best renal replacement therapy leading to the elimination of ESRDCI. The study was undertaken to characterize and assess the prevalence of itch among patients after renal transplantation. Methods: Between October 2019 and January 2020, we analyzed the data of 197 patients comprising 121 males (61.4%) and 76 females (38.6%) and aged 54.5 ± 13.6 years. The data collection was performed with a specially designed questionnaire. Level of itch after renal transplantation was assessed with the use of a Numeral Rating Scale, a Visual Rating Scale, and 4-Item Itch Questionnaire. Moreover, the previous 3 days of itching were evaluated. Results: The patients suffered from chronic renal disease for 20.2 ± 12.3 years, with a mean time of pre-transplant dialysis of 2.6 ± 2.4 years and a mean time after the KTx of 8.0 ± 6.5 years. The itch was present in 38.6% of the patients during the hemodialysis, and in 73.7% of cases, the itch ceased completely after the successful transplantation. Moreover, only 2.63% of the cases had no improvement. Nevertheless, the itch was reported in 42 (21.3%) renal transplant recipients (RTR), and in 22 (52.4%) cases, the itch appeared after transplantation. The majority of patients suffering from itch were women (54.8%). Itch in the last 3 days was reported in 21 patients. The itch's severity was assessed with a numerical rating scale (NRS), with the worst severity measured at 6 ± 2.2 points indicating moderate itch. In most cases (57.1%), itch affected multiple body areas. Extremities (50%) and the back (50%) were among the most frequently affected areas. The sensation had a mostly short duration and was most frequently reported in the evening. Only eight patients suffered for the whole day. Hot water was the most frequently reported (16.7%) alleviating factor, whilst sweat was responsible for itch aggravation in 35.9% of cases. Conclusion: Our analysis on representative patients' population indicates that itch after KTx is an important problem. Moreover, it is worth noting that more than half of the RTR did not suffer from itch during dialysis.
Authors: Elke Weisshaar; Jacek C Szepietowski; Florence J Dalgard; Simone Garcovich; Uwe Gieler; Ana M Giménez-Arnau; Julien Lambert; Tabi Leslie; Thomas Mettang; Laurent Misery; Ekin Şavk; Markus Streit; Erwin Tschachler; Joanna Wallengren; Sonja Ständer Journal: Acta Derm Venereol Date: 2019-04-01 Impact factor: 4.437
Authors: Milda R Saunders; Ana C Ricardo; Jinsong Chen; Amanda H Anderson; Esteban A Cedillo-Couvert; Michael J Fischer; Jesus Hernandez-Rivera; Margaret T Hicken; Jesse Y Hsu; Xiaoming Zhang; Denise Hynes; Bernard Jaar; John W Kusek; Panduranga Rao; Harold I Feldman; Alan S Go; James P Lash Journal: Medicine (Baltimore) Date: 2020-07-10 Impact factor: 1.817
Authors: Aleksandra A Stefaniak; Agnieszka Zubkiewicz-Kucharska; Łukasz Matusiak; Anna Noczyńska; Jacek C Szepietowski Journal: Dermatol Ther (Heidelb) Date: 2020-06-08
Authors: Piotr K Krajewski; Kinga Tyczyńska; Klaudia Bardowska; Piotr Olczyk; Magdalena Krajewska; Jacek C Szepietowski Journal: Toxins (Basel) Date: 2022-04-30 Impact factor: 5.075
Authors: Piotr K Krajewski; Kinga Tyczyńska; Klaudia Bardowska; Piotr Olczyk; Danuta Nowicka-Suszko; Dariusz Janczak; Hanna Augustyniak-Bartosik; Magdalena Krajewska; Jacek C Szepietowski Journal: J Clin Med Date: 2022-07-25 Impact factor: 4.964
Authors: Aleksandra A Stefaniak; Piotr K Krajewski; Dorota Bednarska-Chabowska; Marek Bolanowski; Grzegorz Mazur; Jacek C Szepietowski Journal: Biology (Basel) Date: 2021-12-15